Linezolid Kabi

Linezolid, the active ingredient in Linezolid Kabi, is an oxazolidinone presented as an injection solution for intravenous use. It treats complicated skin and skin structure infections, community‑acquired bacterial pneumonia, hospital‑acquired pneumonia, and methicillin‑resistant Staphylococcus aureus (MRSA) infections in adult patients.

GNH USA supplies Linezolid Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibacterial used for serious Gram‑positive infections. - Complicated skin and skin structure infections: resolves infections caused by MRSA and other susceptible organisms. - Community‑acquired bacterial pneumonia: provides effective coverage against typical and atypical pathogens. - Hospital‑acquired (nosocomial) pneumonia: treats severe pneumonia caused by resistant Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates MRSA in skin, respiratory and bloodstream infections.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal discomfort. - Diarrhea: loose stools that may be mild to moderate. - Headache: occasional mild to moderate cranial pain. - Vomiting: occasional emesis, usually self‑limiting. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Myelosuppression: thrombocytopenia, anemia or leukopenia requiring monitoring. - Peripheral neuropathy: sensory changes that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance requiring immediate attention.

Use Linezolid with clinical monitoring and consider patient‑specific factors. - Renal impairment: adjust therapy and monitor renal function. - Hepatic impairment: use caution and assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid or monitor for serotonin syndrome. - Hematologic monitoring: check complete blood counts for myelosuppression. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid interacts with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension and serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: may precipitate serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Phenytoin: may lower linezolid levels, assess therapeutic response. - NSAIDs: increased risk of bleeding when combined with thrombocytopenia.